share_log
Moomoo 24/7 ·  Mar 28 07:49
Kiora Pharmaceuticals Shares Are Trading Higher After the Company Announced That It Will Present Additional Data From Its ABACUS-1 Trial of KIO-301 in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment